These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4914973)

  • 41. Investigations concerning the immunoprophylactic effect of the antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children.
    Dragomir I; Iancu V; Călţun M; Raicu M; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):323-9. PubMed ID: 6400306
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacteriological and epidemiological approach to prophylaxis for enteric infection. Effects of peritoneal cells from immunized animals on the infectivity of Shigella bacillus to HeLa cells.
    Sakaguchi T; Sakaguchi S
    Kitasato Arch Exp Med; 1981 Dec; 54(3-4):41-7. PubMed ID: 6759764
    [No Abstract]   [Full Text] [Related]  

  • 43. Dysentery in patients infected with human immunodeficiency virus in Zimbabwe: an emerging role for Schistosoma mansoni and Escherichia coli O157?
    Gwavava C; Chihota VN; Gangaidzo IT; Gumbo T
    Ann Trop Med Parasitol; 2001 Jul; 95(5):509-13. PubMed ID: 11487372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
    Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
    [No Abstract]   [Full Text] [Related]  

  • 45. [Studies on natural sensitization by intestinal flora, especially by Escherichia. IX. Delayed cross allergic reaction between Escherichia coli and Shigella having O antigen in common indicated by tissue culture-type test of leukocytes].
    TAKAHASHI T
    Arerugi; 1961 Mar; 10():238-43. PubMed ID: 13774893
    [No Abstract]   [Full Text] [Related]  

  • 46. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
    Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
    [No Abstract]   [Full Text] [Related]  

  • 48. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anti-dysentery vaccination. X. Conjunctival vaccination of guinea pigs with non-pathogenic live Sh. flexneri 2a dysenteric bacilli].
    Istrati G; Istrati M
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):289-98. PubMed ID: 5877471
    [No Abstract]   [Full Text] [Related]  

  • 50. Acute bacterial diarrhoeas due to salmonella, shigella and enteropathogenic Escherichia coli in Zambia.
    Dube SD
    Med J Zambia; 1984 Sep; 18(3):26-9. PubMed ID: 6400676
    [No Abstract]   [Full Text] [Related]  

  • 51. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Considerations on the control of infectious diarrhea].
    Simmons SW; Goodwin MH
    Bol Oficina Sanit Panam; 1966 Apr; 60(4):293-9. PubMed ID: 4222502
    [No Abstract]   [Full Text] [Related]  

  • 53. Detection of Shigella and enteroinvasive Escherichia coli using polymerase chain reaction.
    Ye LY; Lan FH; Zhu ZY; Chen XM; Ye XL
    J Diarrhoeal Dis Res; 1993 Mar; 11(1):38-40. PubMed ID: 8315253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serologic analysis of Escherichia K12 HfrCxShigella flexneri 1a recombinants.
    Mróz E
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):387-401. PubMed ID: 4581241
    [No Abstract]   [Full Text] [Related]  

  • 56. The molecular evolutionary history of Shigella spp. and enteroinvasive Escherichia coli.
    Peng J; Yang J; Jin Q
    Infect Genet Evol; 2009 Jan; 9(1):147-52. PubMed ID: 19000785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Free holiday is offered to volunteers willing to test diarrhoea vaccine.
    Lenzer J
    BMJ; 2010 Jan; 340():c49. PubMed ID: 20051470
    [No Abstract]   [Full Text] [Related]  

  • 58. Mixed bacterial infections in relation to antibiotic activities. IV. Shigella-Escherichia coli infections.
    FRIEDMAN DR; HALBERT SP
    J Immunol; 1960 Jan; 84():11-9. PubMed ID: 13825099
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombination between Escherichia coli and rough forms of Shigella flexneri.
    Rowi0nski S
    Arch Immunol Ther Exp (Warsz); 1969; 17(2):159-63. PubMed ID: 4894352
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of a pulmonary model for immunological characterization of dysentery in children].
    Ivanova VV
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):53-7. PubMed ID: 4898176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.